☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Johnson & Johnson
Johnson & Johnson Reports the Acquisition of Shockwave Medical to Strengthen its MedTech Cardiovascular Portfolio
April 5, 2024
Johnson & Johnson’s Opsynvi (macitentan and tadalafil) Receives the US FDA’s Approval for the Treatment of Pulmonary Arterial Hype...
March 26, 2024
Johnson & Johnson Reports the US FDA ODAC’s Recommendation of Carvykti for Treating Relapsed/Refractory Multiple Myeloma
March 18, 2024
PharmaShots Weekly Snapshots (March 11 – March 15, 2024)
March 15, 2024
Johnson & Johnson Reports sBLA Submission of Tremfya (Guselkumab) to the US FDA for Treating Ulcerative Colitis
March 12, 2024
Johnson & Johnson Reports Type II Variation Application Submission to the EMA for Darzalex as a Treatment of Multiple Myeloma
March 7, 2024
Load more...
Back to Home